Table 2 of
Chua, Mol Vis 2012; 18:431-438.
Table 2. Aqueous cytokine concentrations in glaucoma and non-glaucomatous cataract groups.
Cataract (n=23) | Glaucoma (n=38) | |||||||
---|---|---|---|---|---|---|---|---|
Cytokines | Median | Range | Measurable | Median | Range | Measurable | p-valuea | Sensitivity |
IL-2* | 2.16 | 0–8 | 14/23 | 3.01 | 0–27 | 34/38 | 0.154 | 1.6 |
IFN-γ* | 12.73 | 0–91 | 12/23 | 26.98 | 0–1167 | 36/38 | 0.002 | 6.4 |
IL-13 | 3.85 | 0–8 | 19/23 | 4.82 | 0–46 | 35/38 | 0.432 | 0.7 |
IL-17 | 2.27 | 0–11 | 8/23 | 3.98 | 0–241 | 22/38 | 0.227 | 3.3 |
IL-6* | 2.23 | 0–14 | 9/23 | 4.02 | 0–89 | 27/38 | 0.789 | 2.6 |
IL-10* | 1.45 | 0–5 | 18/23 | 1.91 | 0–64 | 37/38 | 0.050 | 0.3 |
IL-12* | 7.15 | 0–27 | 17/23 | 14.06 | 0–68 | 36/38 | 0.003 | 3.5 |
IL-1β* | 0.60 | 0–6 | 14/23 | 0.72 | 0–5 | 33/38 | 1.000 | 0.6 |
TNF-α* | 9.58 | 0–34 | 16/23 | 12.65 | 0–82 | 35/38 | 0.086 | 6.0 |
IL-1Ra | 8.58 | 3–96 | 10/17 | 8.74 | 0–84 | 14/34 | 1.000 | 5.5 |
IL-15 | 8.50 | 6–29 | 17/17 | 9.00 | 0–26 | 33/34 | 1.000 | 2.4 |
IFN-α* | 26.24 | 0–139 | 16/22 | 37.90 | 0–311 | 37/38 | 0.034 | 4.3 |
CCL2 | 180.89 | 32–962 | 23/23 | 295.22 | 0–1072 | 37/38 | 0.086 | 1.1 |
CCL4 | 16.94 | 4–137 | 23/23 | 33.06 | 1–229 | 37/38 | 0.056 | 2.4 |
CCL5 | 6.30 | 0–25 | 16/17 | 6.30 | 0–39 | 33/34 | 1.000 | 1.8 |
CCL11 | 4.90 | 0–10 | 12/17 | 5.50 | 0–17 | 29/34 | 1.000 | 2.5 |
CXCL8 | 3.08 | 1–20 | 22/23 | 5.58 | 0–81 | 36/38 | 0.060 | 1.0 |
CXCL9* | 62.20 | 0–3603 | 18/20 | 214.97 | 21–1351 | 38/38 | 0.006 | 1.2 |
CXCL10 | 56.27 | 0–5038 | 20/22 | 147.93 | 0–4677 | 37/38 | 0.290 | 6.1 |
IL-7* | 1.09 | 0–15 | 10/23 | 1.92 | 0–4 | 31/38 | 0.728 | 1.1 |
IL-9* | 5.50 | 0–11 | 15/17 | 7.57 | 0–17 | 33/34 | 0.032 | 2.5 |
GM-CSF* | 135.45 | 0–766 | 18/23 | 164.05 | 0–6815 | 37/38 | 0.301 | 2.2 |
PDGF-BB | 3.11 | 0–14 | 11/17 | 2.26 | 0–9 | 27/34 | 1.000 | 2.9 |
Basic-FGF | 10.62 | 7–44 | 17/17 | 11.39 | 0–35 | 33/34 | 1.000 | 1.9 |
VEGF | 43.73 | 22–124 | 17/17 | 54.35 | 0–151 | 33/34 | 1.000 | 3.1 |